You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Colorcon
Medtronic
Express Scripts
Harvard Business School

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BBI608


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Clinical Trials for BBI608

Trial ID Title Status Sponsor Phase Summary
NCT01325441 A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies Recruiting Boston Biomedical, Inc Phase 1/Phase 2 This is an open label, single arm phase 1 dose escalation study and phase 2 study of BBI608 in combination with paclitaxel in patients with advanced malignancies.
NCT01775423 A Study of BBI608 in Adult Patients With Advanced Malignancies Active, not recruiting Boston Biomedical, Inc Phase 1/Phase 2 This is an open label, single arm, dose escalation study of BBI608 in patients with advanced malignancies.
NCT01776307 A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer Recruiting Boston Biomedical, Inc Phase 2 This is an open label, multi-center, Phase 2 study of BBI608 in combination with cetuximab, panitumumab or capecitabine in patients with advanced colorectal cancer.
NCT01830621 BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Patients With Pretreated Advanced Colorectal Carcinoma Completed Boston Biomedical, Inc Phase 3 The purpose of this study is to find out whether it is better to receive a new drug, BBI608, or better to receive no further treatment for colon or rectal cancer. To do this, half of the patients in this study will get BBI608 and the other half will receive a placebo (a substance that is designed not to do anything).
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for BBI608

Condition Name

Condition Name for
Intervention Trials
Cancer 3
Colorectal Cancer 2
Metastatic Colorectal Cancer 2
Hepatocellular Carcinoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for
Intervention Trials
Colorectal Neoplasms 6
Carcinoma 3
Neoplasms 3
Adenocarcinoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for BBI608

Trials by Country

Trials by Country for
Location Trials
United States 98
Japan 27
Canada 18
Australia 16
China 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for
Location Trials
Texas 7
Indiana 7
Colorado 6
Arizona 5
Washington 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for BBI608

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 3 5
Phase 2 2
Phase 1/Phase 2 8
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Recruiting 14
Active, not recruiting 4
Completed 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for BBI608

Sponsor Name

Sponsor Name for
Sponsor Trials
Boston Biomedical, Inc 18
Sumitomo Dainippon Pharma Co., Ltd. 4
Australasian Gastro-Intestinal Trials Group 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for
Sponsor Trials
Industry 22
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Johnson and Johnson
Express Scripts
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.